European Commissioner Valdis Dombrovskis speaks during an online news conference on Friday
Copyright 2020 The Associated Press. All Rights Reserved
Switzerland is among the countries exempt from the European Union’s vaccine export controls, the European Commission said on Friday. The plan has been drawn up to ensure that the EU has enough supplies of Covid-19 vaccine.
This content was published on
2 minutes
Reuters/Keystone-SDA/SWI swissinfo.ch/ilj
EU trade commissioner Valdis Dombrovskis told a news conference that the export monitoring and controls were “time limited”, initially lasting until the end of March, and applied to Covid-19 vaccines the EU had bought in advance.
The bloc could block the export of a vaccine if it determined that this could undermine the EU’s own supplies. The European Commission has however stressed that this is not an export ban.
Donations to COVAX, designed for poorer countries, will be exempted, as will a large number of EU neighbours, including Norway, Switzerland and countries of the western Balkans and North Africa. But Britain will not be exempted.
In a response to the Swiss news agency Keystone-SDA, the Swiss Federal Office of Public Health (FOPH) declined to comment on the decision, saying that it was too early to make a statement
Drugmakers will have to request export authorisation in the EU country where the vaccine is manufactured. That country would consult with the Commission to take a decision in two working days.
The EU has publicly rebuked Anglo-Swedish AstraZeneca for failing to deliver vaccine shots as promised. EU countries have also received fewer deliveries of the Pfizer-BioNTech and Moderna vaccines than expected. Switzerland is affected by the temporary Pfizer-BioNTech and Moderna vaccine shortage.
On Friday evening, the Swiss authorities said around 500,000 vaccine doses had been delivered to Switzerland so far.
More
More
Novartis agrees to help Pfizer-BioNTech produce Covid-19 vaccine
This content was published on
Swiss pharma giant Novartis says it has signed an initial agreement to provide manufacturing capacity for Pfizer and BioNTech’s Covid-19 vaccine.
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Why Swiss participation in WHO’s Covid-19 vaccine plan matters
This content was published on
As the second coronavirus wave makes finding vaccines even more urgent, we look at Swiss participation in the WHO's vaccine pool.
This content was published on
Switzerland will be affected by the temporary delay to the Pfizer-BioNTech Covid-19 vaccine in Europe, the Swiss health authorities have confirmed.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.